Sava Technologies

Raised $35.9M in a Series B round, announced 9 October 2026.

Round

Sava Technologies raised €32.08 million in Series B funding led by Ascensia to scale manufacturing and prepare its glucose microsensor for commercialization.

Amount: $35.9M
Stage: Series B
Announced: 9 October 2026
Investors: Ascensia, Balderton Capital, Norrsken VC, Simplyhealth Ventures, JamJar Investments, Pentland Ventures
Checked: Amount and date checked against the press source

Company

Develops wearable biosensors that continuously detect glucose and other molecules

Based in: London, United Kingdom
Sector: Health
Website: sava.health ↗

Sources and links

Source: London’s Sava raises €32.08 million and partners with Ascensia to bring its glucose microsensor to Europe eu-startups.com
Website: sava.health ↗

Just raised?

MediaBoost gets your round in front of the press, future hires and your next investors.

Announce your round with MediaBoost